CYP2E1 degradation by in vitro reconstituted systems: role of the molecular chaperone hsp90 - PubMed (original) (raw)
. 2000 Jul 15;379(2):321-30.
doi: 10.1006/abbi.2000.1870.
Affiliations
- PMID: 10898951
- DOI: 10.1006/abbi.2000.1870
CYP2E1 degradation by in vitro reconstituted systems: role of the molecular chaperone hsp90
T Goasduff et al. Arch Biochem Biophys. 2000.
Abstract
One major mode of regulation of cytochrome P450 2E1 (CYP2E1) is at the posttranscriptional level, since many low-molecular-weight compounds stabilize the enzyme against proteolysis by the proteasome complex. In an in vitro system containing human liver microsomes, degradation of CYP2E1 in the microsomes required addition of the human liver cytosol fraction in a reaction sensitive to inhibitors of the proteasome complex. It is not clear how CYP2E1 in the microsomal membrane becomes accessible to the cytosolic proteasome. Since molecular chaperones play a role in protein folding and degradation, the possible role of heat shock proteins in CYP2E1 degradation by this reconstituted system was evaluated. Degradation of CYP2E1 required ATP; ATP-gammaS, a nonhydrolyzable analogue of ATP, did not catalyze CYP2E1 degradation by the cytosol fraction, indicating that ATP hydrolysis is required. Geldanamycin, a specific inhibitor of hsp90, inhibited the degradation of microsomal CYP2E1 by the cytosol fraction. Control experiments indicated that geldanamycin was not a substrate/ligand of CYP2E1 nor did it prevent microsomal lipid peroxidation, a process which increases CYP2E1 turnover. Inhibition by geldanamycin was prevented by molybdate. Both of these compounds have been shown to promote alterations in hsp90 structure and to modulate hsp90-protein interactions. The proteasome activity in the cytosol, as assayed by the cleavage of a fluorogenic peptide, was enhanced when ATP was added and inhibited by 30-40% by geldanamycin, effects that are similar, although less pronounced, to the degradation of CYP2E1 by the cytosol. Purified 20S proteasome could catalyze degradation of CYP2E1; however, in an assay using equal peptidase activity, the cytosol fraction was much more effective than the 20S proteasome in promoting CYP2E1 degradation. Immunodepletion of hsp90 from the cytosol resulted in prevention of the degradation of CYP2E1, a reaction that was reversed by the addition of pure hsp90 to this cytosol. These results suggest that in addition to the proteasome, the cytosol fraction contains other factors that modulate the efficiency of CYP2E1 degradation. The sensitivity to geldanamycin and molybdate and the immunodepletion experiments suggest that hsp90 is one of these factors that interact with CYP2E1 and/or with the proteasome to promote the degradation of this microsomal P450.
Copyright 2000 Academic Press.
Similar articles
- NADPH-dependent microsomal electron transfer increases degradation of CYP2E1 by the proteasome complex: role of reactive oxygen species.
Goasduff T, Cederbaum AI. Goasduff T, et al. Arch Biochem Biophys. 1999 Oct 15;370(2):258-70. doi: 10.1006/abbi.1999.1399. Arch Biochem Biophys. 1999. PMID: 10510285 - Role of the proteasome complex in degradation of human CYP2E1 in transfected HepG2 cells.
Yang MX, Cederbaum AI. Yang MX, et al. Biochem Biophys Res Commun. 1996 Sep 24;226(3):711-6. doi: 10.1006/bbrc.1996.1418. Biochem Biophys Res Commun. 1996. PMID: 8831679 - Proteasome-dependent degradation of cytochromes P450 2E1 and 2B1 expressed in tetracycline-regulated HeLa cells.
Huan JY, Streicher JM, Bleyle LA, Koop DR. Huan JY, et al. Toxicol Appl Pharmacol. 2004 Sep 15;199(3):332-43. doi: 10.1016/j.taap.2003.12.019. Toxicol Appl Pharmacol. 2004. PMID: 15364548 - Hsp90 inhibitors: small molecules that transform the Hsp90 protein folding machinery into a catalyst for protein degradation.
Blagg BS, Kerr TD. Blagg BS, et al. Med Res Rev. 2006 May;26(3):310-38. doi: 10.1002/med.20052. Med Res Rev. 2006. PMID: 16385472 Review. - New insights into the mechanisms and importance of the proteasome in intracellular protein degradation.
Goldberg AL, Akopian TN, Kisselev AF, Lee DH, Rohrwild M. Goldberg AL, et al. Biol Chem. 1997 Mar-Apr;378(3-4):131-40. Biol Chem. 1997. PMID: 9165063 Review.
Cited by
- Inhibition of Hsp72-mediated protein refolding by 4-hydroxy-2-nonenal.
Carbone DL, Doorn JA, Kiebler Z, Sampey BP, Petersen DR. Carbone DL, et al. Chem Res Toxicol. 2004 Nov;17(11):1459-67. doi: 10.1021/tx049838g. Chem Res Toxicol. 2004. PMID: 15540944 Free PMC article. - Implication of altered proteasome function in alcoholic liver injury.
Osna NA, Donohue TM Jr. Osna NA, et al. World J Gastroenterol. 2007 Oct 7;13(37):4931-7. doi: 10.3748/wjg.v13.i37.4931. World J Gastroenterol. 2007. PMID: 17854134 Free PMC article. Review. - CYP2E1-dependent hepatotoxicity and oxidative damage after ethanol administration in human primary hepatocytes.
Liu LG, Yan H, Yao P, Zhang W, Zou LJ, Song FF, Li K, Sun XF. Liu LG, et al. World J Gastroenterol. 2005 Aug 7;11(29):4530-5. doi: 10.3748/wjg.v11.i29.4530. World J Gastroenterol. 2005. PMID: 16052683 Free PMC article. - Two distinct pathways mediated by PA28 and hsp90 in major histocompatibility complex class I antigen processing.
Yamano T, Murata S, Shimbara N, Tanaka N, Chiba T, Tanaka K, Yui K, Udono H. Yamano T, et al. J Exp Med. 2002 Jul 15;196(2):185-96. doi: 10.1084/jem.20011922. J Exp Med. 2002. PMID: 12119343 Free PMC article. - TRiC/CCT cooperates with different upstream chaperones in the folding of distinct protein classes.
Siegers K, Bölter B, Schwarz JP, Böttcher UM, Guha S, Hartl FU. Siegers K, et al. EMBO J. 2003 Oct 1;22(19):5230-40. doi: 10.1093/emboj/cdg483. EMBO J. 2003. PMID: 14517260 Free PMC article. Retracted.